findmyKOL
Clinical trialNCT01852136CompletedObservational

Clinical Evaluation of BD NEXT Pen Needle

SponsorBecton, Dickinson and CompanyEnrollment217Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This prospective, multi-center, 2 period cross-over study is designed to determine if people who use injection pens for subcutaneous medication delivery prefer the BD NEXT pen needle (PN) in comparison with currently marketed pen needles of the same or similar gauge and length. Subjects will use the investigational (BD NEXT) PN and their usual conventional PN each for one week in a randomly assigned sequence, and will be asked to evaluate and compare characteristics of the BD NEXT pen needle versus their usual pen needle when used for all their pen injections performed at home. Since injection experience may vary according to the type of pen device used, equal numbers of subjects will be recruited who are users of three of the most commonly used insulin pen injectors.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Lmc Endocrinology Center

    Toronto, Ontario, Canada

United States
  • Physicians Research Center

    Toms River, New Jersey, United States

  • Mountain Diabetes and Endocrine Center

    Asheville, North Carolina, United States

  • Holston Medical Group

    Kingsport, Tennessee, United States

  • Corporation Lane Internal Medicine and Research Center

    Virginia Beach, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2012
Primary completion
31 Dec 2012
Completion
31 Dec 2012
Last update posted
9 Feb 2017
Registered enrollment
217
Registry id
NCT01852136

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.